Table 4.
Comparison of the Cooperative Ocular Oncology Group (COOG) [2] and CLEAR studies.
| COOG [2] | CLEARa | |||
|---|---|---|---|---|
| Class 1 | Class 2 | Class 1 | Class 2 | |
| n (%) | 276 (61.9%) | 170 (38.1%) | 37 (52.8%) | 33 (47.2%) |
| Age (yrs) (median, mean) | 59, 59.6 | 65.9, 65.3 | 62, 60.5 | 63, 62.7 |
| Tumor diameter (mm) (median, mean) |
12.0, 12.1 | 14.0, 13.9 | 12.7, 12.8 | 16, 15.64 |
| Tumor thickness (mm) (median, mean) |
5.0, 5.7 | 6.2, 7.0 | 5, 5.89 | 7.1, 7.02 |
| Ciliary body involvement | 61 (22.7%) | 72 (43.6%) | 15 (41%) | 12 (36%) |
| 3-year metastasis-free survival | 97% | 50% | 100% | 63% |
aThe CLEAR study is a registry and therefore may not be entirely reflective of the general population of UM patients.